Robert Azelby insider trades
Open-market stock purchases and sales by Robert Azelby, Director at Autolus Therapeutics plc, from SEC Form 4 filings since Nov 1, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Bought (not open market) | — |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Bought (not open market) | — |
| Jun 19, 2026 | TNGX Tango Therapeutics, Inc | Bought (not open market) | — |
| Jun 19, 2026 | TNGX Tango Therapeutics, Inc | Bought (not open market) | — |
| Jun 3, 2026 | ADCT ADC Therapeutics SA | Sold (not open market) | $38.8K |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | Bought (not open market) | — |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc | Sold (not open market) | $372K |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc | Sold (not open market) | $58.7K |
| Feb 1, 2026 | TERN Terns Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 5, 2025 | CAH Cardinal Health Inc | Bought (not open market) | — |
Companies traded
- AUTL Autolus Therapeutics plc: other filings, last Jun 29, 2026
- TNGX Tango Therapeutics, Inc: other filings, last Jun 19, 2026
- ADCT ADC Therapeutics SA: 1 sale, last Jun 3, 2026
- TERN Terns Pharmaceuticals, Inc: other filings, last May 5, 2026
- CAH Cardinal Health Inc: other filings, last Nov 5, 2025
- KDNY Chinook Therapeutics, Inc: other filings, last Aug 11, 2023
- ELYM Eliem Therapeutics, Inc: other filings, last Oct 31, 2022
- CLVS Clovis Oncology, Inc: other filings, last Jun 10, 2021
- IMMU Immunomedics Inc: other filings, last Oct 23, 2020
- ALDR Alder Biopharmaceuticals Inc: other filings, last Oct 22, 2019
- CASC Cascadian Therapeutics, Inc: other filings, last Mar 9, 2018
- JUNO Juno Therapeutics, Inc: 12 sales, last Mar 5, 2018